News & Opinion

» genetics & genomics and techniques

Covering the life sciences inside and out

Most Recent

Two freely available databases include data on hundreds of human cancer cell lines. 

1 Comment

A new method stimulates B cells to make human antigen-specific antibodies, obviating the need for vaccinating blood donors or hunting for rare B cells.

0 Comments

image: First Genetic Screen of Pigs Using ENU

First Genetic Screen of Pigs Using ENU

By | July 14, 2017

Using the mutagenic chemical N-ethyl-N-nitrosourea, researchers confirm the role of a gene in a piglet deformity and identify potential models for human diseases. 

0 Comments

image: Mini-Metagenomics Leads to Microbial Discovery

Mini-Metagenomics Leads to Microbial Discovery

By | July 14, 2017

Researchers develop a method that combines the strengths of shotgun metagenomics and single-cell genome sequencing in a microfluidics-based platform.

0 Comments

image: Anti-CRISPR Protein Reduces Off-Target Effects

Anti-CRISPR Protein Reduces Off-Target Effects

By | July 12, 2017

AcrIIA4, an inhibitor protein from the Listeria bacteriophage, can block DNA from binding to Cas9 during genome editing.

0 Comments

image: Electrical Stimulation Steers Neural Stem Cells

Electrical Stimulation Steers Neural Stem Cells

By | July 3, 2017

Current can guide implanted cells away from rats’ noses toward a region deep in their brains.

0 Comments

An analysis of human cancer genome projects uncovers a counterintuitive loss of ribosomal gene copies.

0 Comments

The discovery of peptides, enzymes, and other gene products that confer antibiotic resistance could give clues to how it develops.

1 Comment

image: Genes Tied to Wasps Recognizing Faces

Genes Tied to Wasps Recognizing Faces

By | June 14, 2017

The brains of Polistes paper wasps express different genes when identifying faces than when distinguishing between simple patterns, a study finds.

1 Comment

image: Was a Drop in CRISPR Firms’ Stock Warranted?

Was a Drop in CRISPR Firms’ Stock Warranted?

By | June 7, 2017

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

5 Comments

Popular Now

  1. A Newly Identified Species Represents Its Own Eukaryotic Lineage
  2. Man Receives First In Vivo Gene-Editing Therapy
  3. Telomere Length and Childhood Stress Don’t Always Correlate
  4. Optogenetic Therapies Move Closer to Clinical Use
RayBiotech